Adam Scott Levy
CIK 1693134 · CFO and Secretary · last filed 2026-02-20
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$1.33M
Companies
3
Total Filings
37
Lifetime Open-Market Net
-$9.01M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| MLYS | CFO and Secretary | 48,538 | $27.38 | $1.33M | -$9.06M | 16 | 2026-02-20 |
| Fresh Tracks Therapeutics, Inc. (BBI) Delisted | Chief Business Officer | — | $2.35 | — | $0 | 1 | 2020-03-18 |
| Viridian Therapeutics, Inc.\DE (MGEN) Delisted | Chief Business Officer | 13,040 | — | — | $51.5K | 8 | 2019-02-08 |
Recent Filings · Page 2 of 4
37 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-07-28 | MLYS | Notice (144) | −12,946 | -$181.8K | EDGAR |
| 2025-07-15 | MLYS | Sell (S) | −10,758 | -$155.5K | EDGAR |
| 2025-07-11 | MLYS | Notice (144) | −10,758 | -$155.5K | EDGAR |
| 2025-04-15 | MLYS | Sell (S) | −10,757 | -$129.7K | EDGAR |
| 2025-04-11 | MLYS | Notice (144) | −10,757 | -$129.7K | EDGAR |
| 2025-02-24 | MLYS | Grant (A) | — | $0 | EDGAR |
| 2025-01-15 | MLYS | Sell (S) | −10,757 | -$97.9K | EDGAR |
| 2025-01-13 | MLYS | Notice (144) | −10,757 | -$97.9K | EDGAR |
| 2024-10-15 | MLYS | Sell (S) | −10,757 | -$146.0K | EDGAR |
| 2024-10-11 | MLYS | Notice (144) | −10,757 | -$146.0K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.